Clinical Trial Update: Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

View source ↗

Summary

A completed clinical trial updates the investigation of whether direct-acting antivirals for hepatitis C influence hepatocellular carcinoma recurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Hepatocellular Carcinoma

Drugs mentioned

• Direct-acting antivirals (direct-acting antivirals)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hepatocellular Carcinoma, Hepatitis C | Status: COMPLETED